Integrative computational simulations and functional assays decode allosteric dysregulation in a pathogenic SIRT6

Haiyue Tang1, Jianyang Ao2, Guoyou Zhang3

  • 1Shanghai Key Laboratory of Flexible Medical Robotics, Institute of Medical Robotics, Artificial Intelligence Clinical Research Center for Drug Discovery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China; School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, China; Department of Pharmaceutical and Artificial-Intelligence Sciences, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200025, China.

Insights

A colorectal cancer mutation (L197P) in SIRT6 protein destabilizes its structure, reducing its DNA repair and tumor suppression activity. This study reveals the structural mechanism behind impaired SIRT6 function in cancer.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • SIRT6 is a key NAD+-dependent deacetylase involved in DNA repair, aging, and tumor suppression.
  • Mutations in SIRT6 are found in various cancers, but their structural impact is poorly understood.

Purpose of the Study:

  • To elucidate the structural mechanisms by which the L197P mutation in SIRT6 affects its catalytic activity.
  • To understand the implications of SIRT6 dysfunction in colorectal cancer.

Main Methods:

  • Molecular dynamics simulations to analyze the effect of L197P mutation on SIRT6 structure and dynamics.
  • Markov state model analysis to identify conformational changes.
  • Enzymatic assays to measure deacetylation efficiency.

Main Results:

  • The L197P mutation destabilizes the substrate-binding loop (B-loop) of SIRT6, reducing substrate affinity.
  • Simulations showed weakened interactions with acetylated substrates and increased catalytic distance.
  • Markov state model analysis revealed a novel inactive conformation in the mutant.
  • Enzymatic assays demonstrated a six-fold reduction in deacetylation efficiency for the L197P mutant.

Conclusions:

  • The L197P mutation compromises SIRT6 function by altering its structure and reducing catalytic efficiency.
  • These findings provide mechanistic insights into SIRT6 allosteric regulation and its role in tumorigenesis.

Related Concept Videos

Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation01:08

Allosteric Regulation

Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...